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AbstrAct
Spastic paraplegia, optic atrophy, and neuropathy (SPOAN) is an autosomal recessive 
complicated form of hereditary spastic paraplegia, which is clinically defined by congenital 
optic atrophy, infancy-onset progressive spastic paraplegia and peripheral neuropathy. 
In this study, which included 61 individuals (age 5–72 years, 42 females) affected by 
SPOAN, a comprehensive motor and functional evaluation was performed, using modified 
Barthel index, modified Ashworth scale, hand grip strength measured with a hydraulic 
dynamometer and two hereditary spastic paraplegia scales. Modified Barthel index, which 
evaluate several functional aspects, was more sensitive to disclose disease progression than 
the spastic paraplegia scales. Spasticity showed a bimodal distribution, with both grades 
1 (minimum) and 4 (maximum). Hand grip strength showed a moderate inverse correlation 
with age. Combination of early onset spastic paraplegia and progressive polyneuropathy 
make SPOAN disability overwhelming. 
Key words: hereditary spastic paraplegia, peripheral nervous system disorder, optic 
atrophy, scales, psychomotor performance. 
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resumo
A paraplegia espástica, atrofia óptica e neuropatia (SPOAN) é uma forma complicada de 
paraplegia espástica de herança autossômica recessiva, caracterizada por atrofia óptica 
congênita, paraplegia espástica progressiva de início na infância e neuropatia periférica. 
Este estudo avaliou o desempenho motor e funcional de 61 indivíduos com SPOAN (5 a 
72 anos), por meio do índice de Barthel modificado, a escala modificada de Ashworth, 
da avaliação da força de preensão das mãos com dinamômetro hidráulico de Jamar e 
escalas de paraplegia espástica hereditária. O índice de Barthel modificado, que investiga 
aspectos funcionais, mostrou-se mais sensível para avaliar a progressão da doença do que 
as escalas de paraplegia espástica. A espasticidade apresentou distribuição bimodal, com 
o grau 1 (mínimo) e 4 (máximo). A força de preensão mostrou correlação inversa moderada 
com a idade. A combinação de paraplegia espástica de início precoce com polineuropatia 
progressiva faz da SPOAN uma condição incapacitante. 
Palavras-chave: paraplegia espástica hereditária, doença do sistema nervoso periférico, 
atrofia óptica, escalas, performance psicomotora.
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Spastic paraplegia, optic atrophy and neuropathy 
(SPOAN) (OMIM # 609641) is a neurodegenerative dis-
order recently described in Brazil by our group1,2, in indi-
viduals from Rio Grande do Norte State. This condition is 
characterized by: (a) congenital and non progressive op-
tic atrophy; (b) progressive spastic paraplegia, with onset 
early in life, leading to loss of autonomous ambulation be-
fore adolescence; (c) axonal neuropathy, with clinical on-
set after the first decade of life and causing progressive 
loss of function of upper limbs; (d) startle response with 
unexpected sounds; (e) dysarthria; and (f ) joint retrac-
tions and spine deformities1,2.
Up to now, we are aware of 71 patients with SPOAN, 
belonging to 44 nuclear families, 41 of each are known to 
be consanguineous. Most of them are living in SW Rio 
Grande do Norte state, concentrated in Serrinha dos Pin-
tos and São Miguel municipalities2. It is estimated that 1 
in every 170 inhabitants of Serrinha dos Pintos (popu-
lation in 2000: 4,250) is affected by SPOAN. SPOAN is 
linked to chromosome 11q13, but its responsible gene 
remains unknown. No other form of hereditary spastic 
paraplegia, optic atrophy or neuropathy maps to the same 
chromosomal region of SPOAN1,2. 
The purpose of this study is to perform a quantita-
tive motor and functional evaluation in a series of pa-
tients with SPOAN, in order to better understand disease 
progression and overall performance. As most of those 
individuals are living in small communities, with scarce 
healthcare resources, as a rule they previously had no ac-
cess to any kind of structured rehabilitation program. 
Method
patients
Sixty-one individuals (42 females) with clinical diag-
nosis of SPOAN and in which genetic study demonstrates 
linkage to chromosome 11q13 participate of this study. 
Age at ascertainment ranged from 5 to 72 years [mean 
age of 34 (±13) years]. Clinical data of those patients have 
already been presented elsewhere1,2. Information used in 
this study was collected through direct observation and 
with patients interview, usually conducted close to their 
hometown. 
This study was approved by Biosciences Institute Eth-
ics Committee and an informed consent for participation 
was obtained from patients or their caregivers. 
procedures
The following scales and quantitative instruments 
were used in this study:
(1) The Spastic Paraplegia Rating Scale (SPRS), which 
evaluate 13 variables graded from 0 (normal) to 4 (se-
vere). The maximum obtainable score is 523.
(2) The Functional Hereditary Spastic Paraplegia Rat-
ing Scale (FHSPS), which is a semi-quantitative instru-
ment to measure gait dysfunction level. It is graded from 
0 (normal) to 5 (maximum)4.
(3) The Modified Barthel Index (MBI), to evaluate 
functional performance in 10 functional categories (per-
sonal hygiene, bath, feeding, toilet, stairs climbing, dress-
ing, gait, transfer ability, bowel and bladder control). De-
pendence level was ranked according to achieved perfor-
mance in total (0-24 points), severe (25-50), average (51-
75), and minimum (76-99)5,6.
(4) Sural triceps, quadriceps and hip adductors spas-
ticity was evaluated using Modified Ashworth Scale 
(MAS)7-9.
(5) Left and right hand grip strength was measured 
using a Jamar hydraulic dinamometer (Asimow Eng., 
Trenton, Canada), following established standards. Mean 
value of three attempts with one minute interval was cal-
culated for each hand. Reference values were supplied by 
the manufacturer10,11.
Results 
For data analysis, sample was divided according to age 
in five groups: under 20 years, 20 to 29 years ([20, 30[), 
30 to 39 years ([30, 40[), 40 to 49 years ([40, 50[) and 
above 50 years. 
Table. Mean score, standard deviation, maximum and minimum 
values obtained in the five age groups with the implementation 
of Spastic Paraplegia Rating Scale.
age groups n Mean sD Min Max
< 20 3 35 3 33 38
[20, 30[ 15 41 4 35 48
[30, 40[ 16 41 5 34 50
[40, 50[ 16 43 4 38 51
> 50 10 41 4 37 51
Fig 1. Mean score obtained in five age groups in the Modified Barthel 
Index.
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SPRS was determined in 60 individuals (the 5-year-
old subject was not included), and an average score of 
40.7 points (±5.5) was obtained. Mean scores in five age 
ranges is presented in Table. Lowest individually achieved 
score was of 27 and highest of 52 points; 60% of individ-
uals had score above 40 points. Mean score was not sig-
nificantly different across 5 different ranges of age, and 
remained stable after 20 years of age, with average of 41 
to 43 points. Therefore no correlation was seen between 
SPRS score and age. 
Applying FHSPS to 61 individuals with SPOAN, it was 
determined that 44 (72.1%) had level 5, or maximum, of 
dysfunction, which is characterized by severe loss of gait 
and wheelchair use for more than 50% of time. 14 (22.9%) 
were at level 4, one (1.6%) at level 3 and one (1.6%) at lev-
el 2 of dysfunction. 
BMI, used for functional assessment, disclosed max-
imum level of dependency in 28 individuals (45.9%), to-
tal dependency in 16 (26.2%), average in 14 (22.9%) and 
minimum in 2 (3.3%) subjects. Pearson linear correlation 
coefficient demonstrate a moderate correlation between 
scores and age, demonstrating that individual score de-
creases with age, which means that a functional deterio-
ration occurs in SPOAN (Fig 1). 
According to MAS, lower limbs spasticity had a bi-
modal distribution, with subjects concentration in lev-
els 1 (minimum) and 4 (maximum), as can be appreci-
ated in Figure 2.
Hand grip measurement showed that strength de-
creases with age and that right hand grip was not differ-
ent form left one (Fig 3).
discussion
SPOAN is a complicated form of HSP which leads to 
an early and severe handicap1,2. Nevertheless, SPRS and 
FHSPS, the two available scales for HSP evaluation, were 
not useful indicators of disease progression, as most pa-
tients achieve early in life high scores in both scales. In 
this sense, MBI was more sensitive to appreciate disease 
progression, as it evaluates other functions, some of them 
highly dependable of upper limbs functionality6,12.
Fig 2. Dispersion graphic showing spasticity degree according to Modified Ashworth Scale of mus-
cles sural triceps, quadriceps and hip adductor. Each symbol corresponds to up to two observa-
tions. It can be noted that patients are concentrated in grade 1 (minimum) and 4 (maximum).
4321+10
Sural Triceps
Degree of Spasticity
Quadriceps
Adductor
Age group
  < 20 [20, 30[ [30, 40[ [40, 50[ > 50
LRLRLRLRLR
18
16
14
12
10
8
6
4
2
0
St
re
n
g
th
 (K
g
f)
Right
Left
Fig 3. Mean values in Kgf for the hands grip strength according 
to age group.
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As in SPOAN occurs a combination of upper and low-
er neuron compromise, which progress at different rates 
and have opposite effect on tonus, disease pattern can 
change overtime. Nevertheless, independently of age, in 
some individuals symptoms secondary to lower motoneu-
rons compromise prevail and in other subjects, upper mo-
toneuron clinical manifestations are dominant. Bimodal 
distribution of lower limbs tone, as seen with MAS, is 
probably secondary to this mutually opposed effect of spi-
nal cord and motor neuropathy on tonus.
Hand grip evaluation allows quantification of age re-
lated strength deterioration, secondary to relentless pro-
gression of sensory and motor axonal neuropathy. Loss 
of hands strength correlates positively with neuropathy 
progression. 
This study did not evaluate visual function, which 
might be contributory to dependency. Nevertheless, there 
is no evidence that in SPOAN there is a deterioration of 
visual function and therefore it is not expected to have a 
functional change. For lack of an adequate instrument, it 
was not analyzed the influence on overall performance 
of spine and joints deformities, present in variable de-
gree in most patients.
In summary, this investigation allows quantify the 
motor and functional performance of 61 individuals di-
agnosed with SPOAN and suggests that this complicat-
ed form of HSP has a lifelong progression. Specific scales 
for HSP did not appreciate disease progression, as func-
tional deterioration of lower limbs is an early event and 
achieves a maximum before 20 years of age. By the oth-
er hand, functional scales as BMI, with a more compre-
hensive inventory of evaluated items, perform better for 
investigation of disease progression and overall individ-
ual performance. 
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